Skip to content

COMPARISON OF INFECTIVE COMPLICATIONS IN TWO DIFFERENT TECHNIQUES OF PROSTATIC BIOPSY IN PATIENTS SUSPECTED OF PROSTATE CANCER.

RANDOMISED CLINICAL TRIAL FOR COMPARISON OF INFECTIVE COMPLICATIONS IN TRANSPERINEAL VERSUS TRANSRECTAL ULTRASOUND GUIDED PROSTATIC BIOPSY IN PATIENTS SUSPECTED TO HAVE PROSTATE CANCER. - CPTRTP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/12/006453
Enrollment
220
Registered
2015-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of suspected carcinoma prostate.

Interventions

Intervention1: TRUS GUIDED BIOPSY OF PROSTATE: TRUS guided biopsy of suspected prostate cancer can be done by either by transperineal or transrectal route, study aims to compare the proportion of inf

Sponsors

Department of Urology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patientsrecommended to undergo prostate biopsy for suspected prostate based on one or more of the following : 1. High PSA value(more than 4ng/ml) 2. Abnormal DRE findings; 3. Hypoechoic areas during examination of the prostate by transrectal or abdominal utrasound; 4. Abnormalities identified by MRI of the prostate(such as T2 weighted)

Exclusion criteria

Exclusion criteria: Patients who are unable to undergo TRUS due to any condition such as : 1. Previous proctectomy. 2. Anal stenosis or any painful anal conditions.

Design outcomes

Primary

MeasureTime frame
1. To compare the proportion of different infective complications arising out of the two techniques of transrectal ultrasound guided systematic prostate biopsy in patients suspected to have prostate cancer viz. transrectal and transperineal techniques.Timepoint: December 2016

Secondary

MeasureTime frame
To find out which of the two techniques is associated with: 1. Less discomfort to the patient 2. Greater ease to the urologist. 3. Greater non-infective complications Timepoint: Comfort to the patient and the doctor during the procedure that is prostate biopsy.

Countries

India

Contacts

Public ContactDR SURESH SINGH

JIPMER

dorairajan_ln@hotmail.com04132297332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026